Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.

Niepel M, Hafner M, Mills CE, Subramanian K, Williams EH, Chung M, Gaudio B, Barrette AM, Stern AD, Hu B, Korkola JE; LINCS Consortium, Gray JW, Birtwistle MR, Heiser LM, Sorger PK.

Cell Syst. 2019 Jul 24;9(1):35-48.e5. doi: 10.1016/j.cels.2019.06.005. Epub 2019 Jul 10.

2.

Athletes Play Through Pain - What Does That Mean for Rehabilitation Specialists?

Barrette A.

J Sport Rehabil. 2019 May 16:1-36. doi: 10.1123/jsr.2018-0426. [Epub ahead of print]

PMID:
31094625
3.

Cannabis and the Health and Performance of the Elite Athlete.

Ware MA, Jensen D, Barrette A, Vernec A, Derman W.

Clin J Sport Med. 2018 Sep;28(5):480-484. doi: 10.1097/JSM.0000000000000650. Review.

4.

Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array.

Koch RJ, Barrette AM, Stern AD, Hu B, Bouhaddou M, Azeloglu EU, Iyengar R, Birtwistle MR.

Sci Rep. 2018 Jul 27;8(1):11329. doi: 10.1038/s41598-018-29436-0.

5.

A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens.

Bouhaddou M, Barrette AM, Stern AD, Koch RJ, DiStefano MS, Riesel EA, Santos LC, Tan AL, Mertz AE, Birtwistle MR.

PLoS Comput Biol. 2018 Mar 26;14(3):e1005985. doi: 10.1371/journal.pcbi.1005985. eCollection 2018 Mar. Erratum in: PLoS Comput Biol. 2018 Jul 9;14(7):e1006189.

6.

Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.

Barrette AM, Bouhaddou M, Birtwistle MR.

ACS Chem Neurosci. 2018 Jan 17;9(1):118-129. doi: 10.1021/acschemneuro.7b00197. Epub 2017 Oct 6.

7.

Enhancing Multifunctionalities of Transition-Metal Dichalcogenide Monolayers via Cation Intercalation.

Yu Y, Li G, Huang L, Barrette A, Cai YQ, Yu Y, Gundogdu K, Zhang YW, Cao L.

ACS Nano. 2017 Sep 26;11(9):9390-9396. doi: 10.1021/acsnano.7b04880. Epub 2017 Sep 1.

PMID:
28850781
8.

Efficacy of artesunate + sulphadoxine/pyrimethamine and artemether + lumefantrine and dhfr and dhps mutations in Somalia: evidence for updating the malaria treatment policy.

Warsame M, Hassan AH, Hassan AM, Arale AM, Jibril AM, Mohamud SA, Barrette A, Muse AY, Yusuf FE, Nada RA, Amran JG.

Trop Med Int Health. 2017 Apr;22(4):415-422. doi: 10.1111/tmi.12847. Epub 2017 Feb 24.

9.

Antiinflammatory Effects of Budesonide in Human Fetal Lung.

Barrette AM, Roberts JK, Chapin C, Egan EA, Segal MR, Oses-Prieto JA, Chand S, Burlingame AL, Ballard PL.

Am J Respir Cell Mol Biol. 2016 Nov;55(5):623-632.

10.

Malaria: Global progress 2000 - 2015 and future challenges.

Cibulskis RE, Alonso P, Aponte J, Aregawi M, Barrette A, Bergeron L, Fergus CA, Knox T, Lynch M, Patouillard E, Schwarte S, Stewart S, Williams R.

Infect Dis Poverty. 2016 Jun 9;5(1):61. doi: 10.1186/s40249-016-0151-8.

11.

High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies.

Adeel AA, Elnour FA, Elmardi KA, Abd-Elmajid MB, Elhelo MM, Ali MS, Adam MA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA.

Malar J. 2016 May 21;15(1):285. doi: 10.1186/s12936-016-1339-x.

12.

Expression of human carcinoembryonic antigen-related cell adhesion molecule 6 and alveolar progenitor cells in normal and injured lungs of transgenic mice.

Lin SE, Barrette AM, Chapin C, Gonzales LW, Gonzalez RF, Dobbs LG, Ballard PL.

Physiol Rep. 2015 Dec;3(12). pii: e12657. doi: 10.14814/phy2.12657. Epub 2015 Dec 22.

13.

High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen.

Adeel AA, Saeed NA, Aljasari A, Almohager AM, Galab MH, AlMahdi A, Mahammed MH, AlDarsi M, Salaeah YA, Atta H, Zamani G, Warsame M, Barrette A, Mohammady HE, Nada RA.

Malar J. 2015 Nov 14;14:449. doi: 10.1186/s12936-015-0970-2.

14.

Expression of Carcinoembryonic Cell Adhesion Molecule 6 and Alveolar Epithelial Cell Markers in Lungs of Human Infants with Chronic Lung Disease.

Gonzales LW, Gonzalez R, Barrette AM, Wang P, Dobbs L, Ballard PL.

J Histochem Cytochem. 2015 Dec;63(12):908-21. doi: 10.1369/0022155415603768. Epub 2015 Sep 15.

15.

Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.

Waleh N, Barrette AM, Dagle JM, Momany A, Jin C, Hills NK, Shelton EL, Reese J, Clyman RI.

J Pediatr. 2015 Nov;167(5):1033-41.e2. doi: 10.1016/j.jpeds.2015.07.011. Epub 2015 Aug 8.

16.

Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.

Warsame M, Hassan AM, Barrette A, Jibril AM, Elmi HH, Arale AM, Mohammady HE, Nada RA, Amran JG, Muse A, Yusuf FE, Omar AS.

Trop Med Int Health. 2015 Apr;20(4):510-7. doi: 10.1111/tmi.12458. Epub 2015 Jan 25.

17.

Many-body effects in valleytronics: direct measurement of valley lifetimes in single-layer MoS2.

Mai C, Barrette A, Yu Y, Semenov YG, Kim KW, Cao L, Gundogdu K.

Nano Lett. 2014 Jan 8;14(1):202-6. doi: 10.1021/nl403742j. Epub 2013 Dec 13.

PMID:
24325650
18.

Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.

Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Ringwald P.

Antimicrob Agents Chemother. 2013 Feb;57(2):818-26. doi: 10.1128/AAC.00686-12. Epub 2012 Dec 3.

19.

Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009.

Dorkenoo MA, Barrette A, Agbo YM, Bogreau H, Kutoati S, Sodahlon YK, Morgah K.

Malar J. 2012 Oct 8;11:338. doi: 10.1186/1475-2875-11-338.

Supplemental Content

Loading ...
Support Center